Dr. Farzana Malik has >20 years experience in Pricing, Market Access, Real World Evidence and Health Economics strategy development and implementation for assets across all stages of development from phase 2 to post commercialization.
Farzana has an excellent understanding of payer requirements and excels in developing value arguments for the launch of complex therapies and for rare a diseases, implantable medical devices and new treatments for highly prevalent indications In addition, she has published and presented on these topics at international conferences.
Farzana’s voluntary work includes being a Steering Committee Member of the Rare Disease Interest Group for Health Technology Assessment International. In her spare time, Farzana enjoys hiking, dancing and skiing.
Farzana is happy to collaborate on global and/or EU projects.
Veritux independent consultants are available where you need them – in all major markets and every global region.
